Cite

    Mackiewicz, J. et al. (2018). Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated results. Journal for immunotherapy of cancer. 6 (1), p. . [Online].